Greg McKee

Greg McKee is a seasoned executive with a diverse background in finance, biopharmaceuticals, and corporate development. He studied Economics at the University of Washington before pursuing higher education at the prestigious Wharton School, where he earned an MBA in Finance/Entrepreneurial Management and an MA in International Studies from the Lauder Institute.

Throughout his career, McKee has held various leadership positions in notable organizations, including serving as the Chairman and CEO of Tryp Therapeutics and Executive Chairman of the same organization. Prior to that, he was the President and CEO of CONNECT - San Diego, Akela Pharma, and Nventa Biopharmaceuticals Corporation, where he also served as CFO, VP of Corporate Development, and CEO.

Before entering the biopharmaceutical industry, McKee worked in finance and foreign affairs. He was an Associate Japanese Equity Derivatives at UBS and later served as a Fund Manager and Analyst of Japanese Equity at Mizuho Bank. Additionally, he worked as a Foreign Affairs Advisor for Japan's former Minister for Foreign Affairs, Taro Nakayama.

McKee's extensive experience in both finance and biopharmaceuticals has given him a unique set of skills and expertise. He is particularly versed in corporate development, strategic planning, and business development, with a broad understanding of international affairs.